Total Number of Communication Reports: 54
Monthly communication reports in the last 6 months: 0
End date of the last completed financial year: 2015-12-31
Government Institution | Funding Received in Last Financial Year | Funding Expected in Current Financial Year |
---|---|---|
Australian Government Department of Foreign Affairs and Trade | $3,639,457.74 | Yes |
Irish Aid | $1,554,232.00 | Yes |
Norwegian Agency for Development Cooperation | $815,937.20 | Yes |
Swiss Government SDC | $2,374,944.00 | Yes |
United Kingdom, Department for International Development | $23,343,429.76 | Yes |
United States Agency for International Development | $3,600,657.30 | Yes |
United States National Institutes of Health | $1,432,260.08 | Yes |
Address:
Route de Pré-Bois 20, ICC
Cointrin, Geneva 1216
Switzerland
Telephone number:
+41-22-555-0336
Web address:
www.mmv.org
Matthew Doherty, Manager, Donor and Stakeholder Relations
MMV Medicines for Malaria Venture is not a subsidiary of any other parent companies.
MMV Medicines for Malaria Venture is not a coalition.
The activities of MMV Medicines for Malaria Venture are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
MMV Medicines for Malaria Venture does not have any subsidiaries that could have a direct interest in the outcome of the undertaking
Paul Moen | Public offices held
Firm: Earnscliffe Strategy Group Inc.